By: Hollie Hojek firstname.lastname@example.org Kaitlyn Bourn is spending her Memorial Day Weekend making a splash at AquaVenutre water park in Norfolk, Nebraska. "You just play around here, you play in the waterMore>>
AquaVenture Water Park Opens Up in Norfolk, Nebraska. More>>
By: Hollie Hojek email@example.com For the 3rd Memorial Day Weekend in a row, the Girls of '68 celebrated and shared part of Sioux City's rich history. The local organization dedicated to keeping SiouxMore>>
Girls of '68 Share Story of Sioux City's First White Settler, Theodiphile Bruguier. More>>
By: Diana Johnsen firstname.lastname@example.org On Saturday, at Wal-Mart and the Southern Hills Mall in Sioux City, the Sioux City Police Department helped parents create "children identification kits". TheMore>>
On Saturday, at Wal-Mart and the Southern Hills Mall in Sioux City, the Sioux City Police Department helped parents create "children identification kits". More>>
By: Diana Johnsen email@example.com On your mark…get set...paddle! About 130 kayakers took to the Missouri River in the "3rd Annual South Dakota Kayak Challenge" on Saturday. "It's an opportunityMore>>
About 130 kayakers took to the Missouri River in the "3rd Annual South Dakota Kayak Challenge" on Saturday.More>>
By: Hollie Hojek firstname.lastname@example.org Rain, rain go away, come back and other weekend but this one. The rain in the forecast isn't ruining everyone's plan, but it is keeping some campers away. The sunMore>>
Siouxland Campgrounds Still Packing in the People Despite Poor Weekend WeatherMore>>
By: Tim Seaman email@example.com On Thursday, a pretty cool relay put on by law enforcement officers from across the state ran through central Iowa for the Special Olympics Torch Run. The event helpsMore>>
When the torch arrived Sioux City West sophomore JJ Reeg–Beckner had the honor of igniting the Special Olympic cauldron. Reeg-Beckner was selected from more than 2,500 athletes to finish the run.More>>
By: Channel 9 Eyewitness News (AP) About 110,300 South Dakotans are expected to travel over the Memorial Day holiday weekend, a slight decline from last year. AAA says that mirrors an expected dropMore>>
About 110,300 South Dakotans are expected to travel over the Memorial Day holiday weekend, a slight decline from last year.More>>
By: Channel 9 Eyewitness News (AP) Nebraska students showed improvement in this year's statewide writing proficiency test. Nebraska Education Commissioner Roger Breed announced Friday that 66 percentMore>>
Nebraska students showed improvement in this year's statewide writing proficiency test.
Nebraska Education Commissioner Roger Breed announced Friday that 66 percent of 8th graders met or exceeded state standards, a 2 percent increase over the previous year.More>>
By Channel 9 Eyewitness News firstname.lastname@example.org Iowa investigators say the discovery of blood of a missing 15-year-old girl has diminished hope of finding her alive. Bill Kietzman of the Iowa DivisionMore>>
15-year old Kathlynn Shepard went missing on Monday.More>>
By: Scott Larson email@example.com How comfortable do you feel strolling the streets in Sioux City? That's a question that the Blue Zones Project is asking. And today they brought in an expert toMore>>
Walkable and Livable Communities Institute's Dan Burden assists Sioux City & Blue Zones Project with working out more pedestrian friendly roads.More>>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Pivotal Therapeutics Inc.
WOODBRIDGE, ON, March 6, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on optimizing Omega-3
therapy for cardiovascular disease and overall health, is pleased to
announce it will exhibiting at the American College of Cardiology's 62nd Annual Scientific Session and EXPO (ACC), March 9-11, 2013 at the
Moscone Center in San Francisco, California, Booth # S2544. The ACC is
the largest gathering of cardiovascular products and services, with the
latest advances and solutions in cardiovascular science and care.
"With more that 13,000 cardiovascular professionals attending the ACC,
it is a perfect venue to showcase VASCAZEN® the only prescription Omega-3 therapy specifically formulated for the
correction of an Omega-3 deficiency in cardiovascular patients," said
Dr. George Jackowski, Chairman and Chief Scientific Officer. "Pivotal
will have an opportunity to educate attendees on the benefits patients
see as a result of correcting an Omega-3 deficiency with VASCAZEN®."
About Pivotal Therapeutics Inc.
With offices in Toronto, Canada and Boca Raton, Florida, Pivotal
Therapeutics is a publicly traded (OTCQX: PVTTF) (CNSX: PVO) specialty
pharmaceutical company with a focus on cardiovascular disease and
overall health. Pivotal Therapeutics' lead product VASCAZEN® is a prescription only Medical Food formulated to meet the dietary
Omega-3 deficient needs of patients with cardiovascular disease through
elevating Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) to
levels associated with reduced risk of cardiovascular complications.
VASCAZEN® is a prescription only Medical Food specifically formulated for the
dietary management of an Omega-3 deficiency in cardiovascular patients.
VASCAZEN® is a >90% pure Omega-3 with a proprietary 6:1 EPA:DHA fatty acid
formulation, protected by a series of both U.S. and foreign patents.
This unique formulation provides the cornerstone upon which a family of
cutting edge combination products, with efficacy across a broad
spectrum of cardiac care, will be commercialized.
OMAZENTM is a prescription grade Omega-3 providing >90% total Omega-3 in each
capsule with a unique 6:1 ratio of EPA:DHA. OMAZENTM is a patented product available for sale and distribution in Canada.
Disclosure Notice The information contained in this document is as of March 6, 2013. This
press release contains forward-looking statements. Such forward-looking
statements are subject to a number of risks, assumptions and
uncertainties that could cause Pivotal's actual results to differ
materially from those projected in such forward-looking statements.
These statements can be identified by the use of words such as "will",
"anticipate", "estimate", "expect", "project", "forecast", "intend",
"plan", "believe", "project", "potential", and similar expressions with
any discussion of future operating or financial performance or events.
In particular, factors that could cause actual results to differ
materially from those in forward looking statements include the
following: Pivotal's inability to obtain additional financing on
acceptable terms; growth in costs and expenses; inability to compete
with others who provide comparable products; risk that the Company's
products will not gain widespread market acceptance; risks relating to
the Company's ability to maintain its CSNX listing. Forward-looking
statements speak only as of the date made and are not guarantees of
future performance. The Company undertakes no obligation to publicly
update or revise any forward-looking statements contained in this
document as a result of new information or future events or
developments. CNSX has not reviewed and does not accept responsibility
for the adequacy or accuracy of this information.